BridgeMD
Compares treatment options for Myopia
Official title Software Refraction With Mobilerone Versus Retinoscopy
ClinicalTrials.gov ID: NCT06059521
What this study is testing
- What it's testing
- Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 46. Healthy volunteers may be eligible.
You may be able to join if
- subject with ametropia on each eye ≤-12.00D
- subject with best corrected visual acuity ≥ 20/25, no amblyopia
- subject with normal transparency of eyes
- subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
- subject able to cooperate with the screen and the operator
You likely can't join if
- subject with a topography showing an anomaly (keratoconus type or other)
- subject with hyperopia or presbyopia
- subject with mild myopia ≥ -1.00D
- subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists
See the full eligibility criteria
- subject with ametropia on each eye ≤-12.00D
- subject with best corrected visual acuity ≥ 20/25, no amblyopia
- subject with normal transparency of eyes
- subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
- subject able to cooperate with the screen and the operator
- subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
- non-diabetic subject
- non nystagmus subject
- non-strabismus subject
- subject who has not had eye surgery less than 1 year old
- subject with a topography showing an anomaly (keratoconus type or other)
- subject with hyperopia or presbyopia
- subject with mild myopia ≥ -1.00D
- subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Beijing, Haidian District, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 46 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Beijing, Haidian District, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.